SAN DIEGO--(BUSINESS WIRE)--Dec. 19, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast.
J.P. Morgan Healthcare Conference Presentation, San Francisco, California
Monday, January 8, 2018 at 3:30 pm Pacific Time
J.P. Morgan Healthcare Conference Question & Answer Session, San Francisco, California
Monday, January 8, 2018 at 4:00 pm Pacific Time
The webcasts can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171219005230/en/
Source: Illumina, Inc.
Illumina, Inc.
Investors:
Jacquie Ross, CFA
858-882-2172
ir@illumina.com
or
Media:
Eric Endicott
858-882-6822
pr@illumina.com
